Scorpius Holdings, Inc.
Scorpius Holdings, Inc.
Your view on SCPX
Overview
What the company does, where it operates, and who runs it.
About Scorpius Holdings, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Jeffrey Alan Wolf
- Headquarters
- 627 Davis Drive, Morrisville, NC, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Jeffrey Alan Wolf
- Headquarters
- 627 Davis Drive, Morrisville, NC, US
Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies.
It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays.
The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Scorpius Holdings, Inc., and the rating behind it. SCPX last traded at $0.01; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Scorpius Holdings, Inc.. Starting points for Scorpius Holdings, Inc.: EPS -$0.26, beta 1.42 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Scorpius Holdings, Inc.. Scorpius Holdings, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Scorpius Holdings, Inc.. Trailing twelve-month EPS for Scorpius Holdings, Inc. stands at -$0.26. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Scorpius Holdings, Inc.. Scorpius Holdings, Inc. has reported as a listed company since 2013. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Scorpius Holdings, Inc. valued side by side against its closest peers. Scorpius Holdings, Inc. is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Scorpius Holdings, Inc., and how their positions are changing. At a $130,071 market value, institutional positions materially move Scorpius Holdings, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Scorpius Holdings, Inc. executives and directors. Shares of Scorpius Holdings, Inc. have traded between $0.0001 and $0.22 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Scorpius Holdings, Inc.. Scorpius Holdings, Inc. is a $130,071 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Scorpius Holdings, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Scorpius Holdings, Inc.. Coverage tracks Scorpius Holdings, Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.